← Back to Search

Iron Supplement

Ferrous sulfate for Abnormal Uterine Bleeding

Phase 4
Waitlist Available
Led By Oluyemisi Adeyemi - Fowode, MD
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 week study visit
Awards & highlights

Study Summary

This trial is comparing taking iron every other day to taking iron daily, to see which is better for treating iron deficiency anemia in girls and young women with heavy periods.

Eligible Conditions
  • Abnormal Uterine Bleeding
  • Iron-Deficiency Anemia
  • Menorrhagia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Eligible Patients Enrolled.
Secondary outcome measures
Adherence
Percentage of Enrolled Patients Who Agree to Continue in the Study After Randomization
Retention as Measured by Visit Follow-up Adherence

Side effects data

From 2022 Phase 4 trial • 13 Patients • NCT05007899
60%
Heartburn
60%
Abdominal pain
40%
Constipation
20%
Diarrhea
100%
80%
60%
40%
20%
0%
Study treatment Arm
Daily
Alternate Day

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Alternate DayExperimental Treatment1 Intervention
Patients receive ferrous sulfate 325 mg (65 mg elemental iron) once every other morning.
Group II: DailyActive Control1 Intervention
Patients receive standard regimen of ferrous sulfate 325 mg (65 mg elemental iron) once every morning.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ferrous sulfate
2008
Completed Phase 4
~1970

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
1,001 Previous Clinical Trials
6,002,239 Total Patients Enrolled
Oluyemisi Adeyemi - Fowode, MDPrincipal InvestigatorBaylor College of Medicine
Jacquelyn Powers, MDPrincipal InvestigatorBaylor College of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I satisfy the prerequisites to be enrolled in this experiment?

"This trial demands that enrollees are anemic and between the ages of 9 and 22. The study aims to accept 40 participants in total."

Answered by AI

Has the Federal Drug Administration certified Ferrous sulfate?

"Ferrous sulfate has a favorable safety record, so it received an evaluation of 3. Notably, this medication is already approved and the trial being conducted is at phase 4."

Answered by AI

Has research involving Ferrous sulfate been conducted previously?

"At present, 14 trials examining the efficacy of Ferrous sulfate are underway. Of those experiments, 4 have advanced to Phase 3 testing. 41 medical sites across America are involved in these studies and the bulk of them are situated in Galveston, Texas."

Answered by AI

What ailments is Ferrous sulfate most often prescribed for?

"Ferrous sulfate has proven to be a viable treatment option for individuals struggling with folate deficiency, hypochromic anemia, and breastfeeding mothers."

Answered by AI

Is it possible to join this research experiment at present?

"As reported on clinicaltrials.gov, this medical study is presently enrolling participants. It was initially posted in December of 2020 and then updated most recently in April 2022."

Answered by AI

How many participants have signed up for this research project?

"Affirmative. Clinicaltrials.gov displays that this medical trial, which was uploaded on December 21st 2020, is currently recruiting volunteers. 40 participants must be recruited from a single site to continue the study's progression."

Answered by AI

Is the population of this research endeavor limited to those under 40?

"According to the eligibility criteria, individuals between 9 and 22 years old are invited to participate in this trial. In total, there are 166 trials available for minors and 469 studies catering to those above retirement age."

Answered by AI

Who else is applying?

What state do they live in?
Utah
How old are they?
18 - 65
What site did they apply to?
Texas Children's Pavilion for Women
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Alternate Day Versus Daily Oral Iron Therapy in Adolescents
Jacquelyn Powers, MD, MS 2020. "Alternate Day Versus Daily Oral Iron Therapy in Adolescents". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05007899.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top